JohnRCookMD

PubMed

• 8 citations
  Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.
  Robbin F. Itzler, Po Yen Chen, Christina Lac, Antoine C. El Khoury, John R. Cook> ;Journal of Medical Economics. 2011 Nov 13
• 10 citations
  Healthy-days time equivalents for outcomes of acute rotavirus infections.
  A. Brett Hauber, Robbin F. Itzler, F. Reed Johnson, Ateesha F. Mohamed, Juan Marcos Gonzalez, John R. Cook, Emmanuel B. Walter> ;Vaccine. 2011 Oct 19
• 75 citations
  Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).
  Timo Vesikari, Robbin F. Itzler, David O. Matson, Mathuram Santosham, Celia D. C. Christie, Michele L. Coia, John R. Cook, Gary G. Koch, Penny Heaton> ;International Journal of Infectious Diseases. 2007 Dec 1
• 106 citations
  Cholesterol reduction yields clinical benefits: meta-analysis including recent trials
  A. Lawrence Gould, Glenn M. Davies, Evo Alemao, Donald Yin, John R. Cook> ;Clinical Therapeutics. 2007 May 1
• 15 citations
  Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
  Michele Kohli, Cheryl L. Attard, Annette Lam, Daniel M. Huse, John R. Cook, Chantal Bourgault, Evo Alemao, Donald Yin, Michael A Marentette> ;Pharmacoeconomics. 2006 Jan 1
• 4 citations
  Projected coronary heart disease risk benefit with ezetimibe
  Glenn Davies, John R. Cook, John R. Ii Erbey, Evo Alemao, Enrico P. Veltri> ;Atherosclerosis. 2005 Apr 1
• 14 citations
  Development and validation of a model to project the long-term benefit and cost of alternative lipid-lowering strategies in patients with hypercholesterolaemia
  John R. Cook, Don Yin, Evo Alemao, Michael Drummond> ;Pharmacoeconomics. 2004 Jan 1
• 17 citations
  Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine
  Paul Coplan, John R. Cook, George W. Carides, Joseph F. Heyse, Albert W. Wu, Scott M. Hammer, Bach Yen Nguyen, Anne R. Meibohm, Mark J. DiNubile> ;Clinical Infectious Diseases. 2004 Aug 1
• 22 citations
  Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.
  John R. Cook, Don Yin, Evo Alemao, Glenn Davies, Karl J. Krobot, Enrico P. Veltri, Leslie Lipka, Xavier Badia> ;Pharmacoeconomics. 2004 Jan 1
• 54 citations
  Losartan reduces the costs associated with diabetic end-stage renal disease: The RENAAL study economic evaluation
  William H. Herman, Shahnaz Shahinfar, George W. Carides, Erik J. Dasbach, William C. Gerth, Charles M. Alexander, John R. Cook, William F. Keane, Barry M. Brenner> ;Diabetes Care. 2003 Mar 1
• 116 citations
  Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
  Elizabeth M. Mahoney, Claudine Jurkovitz, Haitao Chu, Edmund R. Becker, Steven D. Culler, Andrzej S. Kosinski, Debbie H. Robertson, Charles M. Alexander, Soma S. Nag, ...> ;JAMA. 2002 Oct 16
• 25 citations
  Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
  Antonio M. Gotto, Stephen J. Boccuzzi, John R. Cook, Charles M. Alexander, James B. Roehm, Gregg S. Meyer, Michael Clearfield, Stephen E. Weis, Edwin J. Whitney> ;The American Journal of Cardiology. 2000 Dec 1
• 20 citations
  Use of an angular transformation for ratio estimation in cost-effectiveness analysis.
  John R. Cook, Joseph F. Heyse> ;Statistics in Medicine. 2000 Nov 15
• 32 citations
  Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival St...
  William H. Herman, Charles M. Alexander, John R. Cook, Stephen J. Boccuzzi, Thomas Musliner, Terje R. Pedersen, John Kjekshus, Kalevi Pyörälä> ;Diabetes Care. 1999 Nov 1
• 20 citations
  The cost and cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction.
  John R. Cook, Henry A. Glick, William C. Gerth, Bruce Kinosian, John B. Kostis> ;American Journal of Hypertension. 1998 Dec 1
• 12 citations
  Time-dependent variability in repeated measurements of cholesterol levels: Clinical implications for risk misclassification and intervention monitoring
  John R. Roeback, John R. Cook, Harry A. Guess, Joseph F. Heyse> ;Journal of Clinical Epidemiology. 1993 Oct 1
• Join now to see all